JPRN-UMIN000007236已完成2 期
A multicenter phase II trial of TS-1+oxaliplatin+panitumumab as first-line treatment in patients with kras-wild type unresectable advanced colorectal liver metastasis. - A multicenter phase II trial of TS-1+oxaliplatin+panitumumab as first-line treatment in patients with kras-wild type unresectable advanced colorectal liver metastasis.
Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences0 个研究点目标入组 2 人开始时间: 2012年2月7日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 2
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) History of severe allergy 2) Administration contraindication of oxaliplatin, panitumumab, TS-1, or 5FU 3) Severe infectious disease 4) Severe complications (interstitial lung disease or pulmonary fibrosis, , kidney failure, hepatic failure, uncontrolable diabetes, uncontrolable hypertension) 5) History of interstitial lung disease or pulmonary fibrosis 6) Severe heart failure or history of severe heart failure 7) Peripheral sensory 8) Wattery diarrhea 9) Massive pleural effusion or ascites 10) Gastrointestinal perforation or bleeding 11) Patient medicated with anticoagulant drugs (except for low-dose aspirin [less than 325mg/day]) 12) Synchronous or metachronous (within 5 years) malignancy other than carcinoma in situ 13) Pregnant or lactating women or women of childbearing potential, and no birth-control 14) Mechanical bowel obstruction 15) Active hepatitis type B 16) Any other cases who are regarded as inadequate for study enrollment by the investigator.
研究者
相似试验
招募中
2 期
Phase II study of TS-1 / oxaliplatin(G-SOX) plus bevacizumab treatment for elderly advanced colorectal cancer patients.(GIANTS study)colorectal cancerJPRN-UMIN000009014niversity of Miyazaki Hospital.50
招募中
1 期
Phase I/II Study of TS-1/Oxaliplatin(SOX) for patients with unresectable advanced or recurrent gastric cancerunresectable advanced or recurrent gastric cancerJPRN-UMIN000015807Gunma University Graduate School of Medicine72
招募中
1 期
Phase I/II study of TS-1 / Oxaliplatin / Radiation for KRAS mutation type locally advanced and recurrent rectal cancer.Advanced or recurrent rectal cancerJPRN-UMIN000006305Graduate School of Medicine, Osaka Univesity31
未知
Unknown
A phase 1/2 trial of Oxaliplatin(L-OHP) + S-1 in patients with previously untreated advanced colorectal cancerColorectal cancerJPRN-jRCT2080220116Yakult Honsha Co.,Ltd.
已完成
1 期
A Phase I/II Study of S-1 and Oxaliplatin Combined With Radiation for Preoperative Locally Advanced Rectal CarcinomaColorectal CancerJPRN-UMIN000017450Japan Clinical Cancer Research Organization45